User profiles for E. Farrow

Emily Farrow

Assistant Professor, UMKC School of Medicine
Verified email at cmh.edu
Cited by 6073

Recent advances in renal phosphate handling

EG Farrow, KE White - Nature Reviews Nephrology, 2010 - nature.com
Phosphate is critical for the maintenance of skeletal integrity, is a necessary component of
important biomolecules, and is central to signal transduction and cell metabolism. It is …

Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units

…, RJ Grocock, EH Margulies, EG Farrow… - Science translational …, 2012 - science.org
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease
presentations are often undifferentiated at birth. More than 3500 monogenic diseases have …

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders

SE Soden, CJ Saunders, LK Willig, EG Farrow… - Science translational …, 2014 - science.org
Neurodevelopmental disorders (NDDs) affect more than 3% of children and are attributable
to single-gene mutations at more than 1000 loci. Traditional methods yield molecular …

Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings

…, SL Tsai, L Zellmer, EG Farrow… - The Lancet …, 2015 - thelancet.com
Background Genetic disorders and congenital anomalies are the leading causes of infant
mortality. Diagnosis of most genetic diseases in neonatal and paediatric intensive care units (…

[HTML][HTML] Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome

…, LD Smith, NA Miller, AM Atherton, EG Farrow… - Genomics, 2013 - Elsevier
Mitochondrial diseases are notoriously difficult to diagnose due to extreme locus and allelic
heterogeneity, with both nuclear and mitochondrial genomes potentially liable. Using exome …

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice

EG Farrow, X Yu, LJ Summers… - Proceedings of the …, 2011 - National Acad Sciences
Autosomal dominant hypophosphatemic rickets (ADHR) is unique among the disorders
involving Fibroblast growth factor 23 (FGF23) because individuals with R176Q/W and R179Q/W …

[HTML][HTML] A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases

NA Miller, EG Farrow, M Gibson, LK Willig, G Twist… - Genome medicine, 2015 - Springer
While the cost of whole genome sequencing (WGS) is approaching the realm of routine
medical tests, it remains too tardy to help guide the management of many acute medical …

Cleidocranial dysplasia: a review of clinical, radiological, genetic implications and a guidelines proposal

E Farrow, R Nicot, A Wiss, A Laborde… - Journal of Craniofacial …, 2018 - journals.lww.com
… Address correspondence and reprint requests to Emilie Farrow, MD, Service de
Chirurgie Maxillo-Faciale et Stomatologie Hôpital Roger Salengro, Bd du Professeur Emile …

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo

Y Rhee, N Bivi, E Farrow, V Lezcano, LI Plotkin… - Bone, 2011 - Elsevier
Mice with constitutive activation of parathyroid hormone (PTH) receptor signaling in osteocytes
(DMP1-caPTHR1 transgenic mice) exhibit increased bone mass and remodeling, two of …

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

EG Farrow, SI Davis, LJ Summers… - Journal of the American …, 2009 - journals.lww.com
Fibroblast growth factor-23 (FGF23), a hormone central to phosphate and vitamin D
metabolism, reduces renal absorption of phosphate by downregulating the sodium-phosphate …